XBI VS FXH

Exchange-Traded Funds (ETFs) have transformed the way investors approach financial markets, providing an avenue for diversified exposure across a wide range of sectors and asset classes. In this article, we'll embark on a comprehensive journey of comparison between two prominent ETFs: XBI (SPDR S&P Biotech ETF) and FXH (First Trust Health Care AlphaDEX Fund). Our exploration will encompass essential aspects such as ETF tickers, full names, issuers, sectors, top holdings, capitalization, investment strategy, tracking methods, and exposure.

XBI Vs FXH: Overview

The XBI and FXH ETFs represent distinct segments of the financial market. XBI, offered by State Street Global Advisors, focuses on the biotechnology sector. On the other hand, FXH, managed by First Trust Advisors, targets the health care industry through the AlphaDEX methodology. This fundamental difference in investment focus sets the stage for a nuanced comparison of these two ETFs.

XBI Vs FXH: Sectors and Top Holdings

The XBI ETF concentrates its portfolio on biotech companies, including renowned names such as Amgen, Moderna, and Regeneron Pharmaceuticals. In contrast, FXH's holdings span various health care subsectors, from pharmaceuticals to medical equipment. Understanding the sectors and top holdings is pivotal for investors seeking exposure to specific segments within the broader health care domain.

XBI overlap XBI VS FXH

XBI Vs FXH: Capitalization and Investment Strategy

XBI boasts a substantial asset under management (AUM), underscoring its popularity among investors keen on tapping into the growth potential of biotechnology. FXH employs the AlphaDEX methodology, a factor-based approach designed to identify health care stocks with superior potential for outperformance. The variance in capitalization and investment strategy presents investors with distinct risk-return profiles to consider.

XBI Vs FXH: Tracking Methods and Exposure

XBI seeks to replicate the performance of the S&P Biotechnology Select Industry Index, offering investors direct exposure to the biotech sector's movements. FXH, utilizing the AlphaDEX methodology, selects health care stocks based on growth and value factors. This leads to a diverse exposure across health care subsectors, potentially mitigating concentration risk associated with individual stocks.

Conclusion

XBI and FXH exemplify the diversity of investment opportunities presented by ETFs within the biotech and health care sectors. Investors seeking to explore the intricacies of these ETFs, including their holdings, correlations, overlaps, and other insights, can leverage ETF insider—an intuitive app that provides comprehensive information on various financial instruments.

Disclaimer: This article does not offer investment advisory services.
Sources:

Get started